153 related articles for article (PubMed ID: 26439936)
21. Effectiveness and safety of iodopovidone in an experimental pleurodesis model.
Teixeira LR; Vargas FS; Puka J; Acencio MM; Antonangelo L; Terra RM; Damico FM; Pitta FG; Marchi E
Clinics (Sao Paulo); 2013 Apr; 68(4):557-62. PubMed ID: 23778345
[TBL] [Abstract][Full Text] [Related]
22. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Quality of Life after Pleurodesis in Patients with Malignant Pleural Effusion.
Terra RM; Costa PB; Dela Vega AJM; Araujo PHXN; Teixeira LR; Pêgo-Fernandes PM
Respiration; 2019; 98(6):467-472. PubMed ID: 31694026
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies.
Agarwal R; Aggarwal AN; Gupta D; Jindal SK
Respir Med; 2006 Nov; 100(11):2043-7. PubMed ID: 16574389
[TBL] [Abstract][Full Text] [Related]
26. Iodopovidone pleurodesis does not effect thyroid function in normal adults.
Yeginsu A; Karamustafaoglu A; Ozugurlu F; Etikan I
Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):563-4. PubMed ID: 17669938
[TBL] [Abstract][Full Text] [Related]
27. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms.
Kelly-Garcia J; Roman-Berumen JF; Ibarra-Perez C
Arch Med Res; 1997; 28(4):583-5. PubMed ID: 9428588
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous octreotide therapy for malignant pleural effusion after pleurodesis with talc powder: a placebo-controlled, triple-blind, randomized trial.
Ershadi R; Vahedi M; Zadeh HK; Fathi F; Ebrahimpour H; Zadeh JS; Rafieian S
Support Care Cancer; 2022 Dec; 30(12):9833-9840. PubMed ID: 36357795
[TBL] [Abstract][Full Text] [Related]
29. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions.
Crnjac A
Wien Klin Wochenschr; 2004; 116 Suppl 2():28-32. PubMed ID: 15506307
[TBL] [Abstract][Full Text] [Related]
30. Malignant pleural effusion treatment outcomes: pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomy.
Luh SP; Chen CY; Tzao CY
Thorac Cardiovasc Surg; 2006 Aug; 54(5):332-6. PubMed ID: 16902882
[TBL] [Abstract][Full Text] [Related]
31. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
[TBL] [Abstract][Full Text] [Related]
32. Pleurodesis with povidone iodine in patients with malignant pleural effusion in a tertiary center in Nigeria.
Omoregbee BI; Okugbo S
Pan Afr Med J; 2021; 38():169. PubMed ID: 33995776
[TBL] [Abstract][Full Text] [Related]
33. [Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
Walter M; Türler A; Schmitz-Rixen T
Zentralbl Chir; 1996; 121(3):216-22. PubMed ID: 8867348
[TBL] [Abstract][Full Text] [Related]
34. Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience.
Bertolaccini L; Viti A; Gorla A; Terzi A
Eur J Surg Oncol; 2012 Dec; 38(12):1161-4. PubMed ID: 22959168
[TBL] [Abstract][Full Text] [Related]
35. Iodopovidone: an inexpensive and effective agent for chemical pleurodesis.
Agarwal R
Lung Cancer; 2007 Feb; 55(2):253-4. PubMed ID: 17118489
[No Abstract] [Full Text] [Related]
36. Iodopovidone as a pleurodesis agent: setting standards for clinical pleural research.
Diacon AH
Respirology; 2010 Jan; 15(1):4-5. PubMed ID: 20199631
[No Abstract] [Full Text] [Related]
37. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
[TBL] [Abstract][Full Text] [Related]
38. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.
Goodman A; Davies CW
Lung Cancer; 2006 Oct; 54(1):51-5. PubMed ID: 16920219
[TBL] [Abstract][Full Text] [Related]
40. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions.
Kishi K; Homma S; Sakamoto S; Kawabata M; Tsuboi E; Nakata K; Yoshimura K
Eur Respir J; 2004 Aug; 24(2):263-6. PubMed ID: 15332395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
